Prostate Cancer and Bone Marrow Involvement

Journal Title: Istanbul Medical Journal - Year 2020, Vol 21, Issue 3

Abstract

Introduction: Bone marrow involvement (BoMI) may be common during the tumour’s lifespan or, sometimes, it may be the first sign of manifestation of a disease. Prostate cancer at an extensive stage has osteoblastic bone metastasis. The purpose of this study is to explore the results of prostate cancer with BoMI that is diagnosed by bone marrow biopsy. Methods: We retrospectively evaluated 55 patients with BoMI of solid tumours and 8 patients with histopathologically proven BoMI of prostate cancer. The overall survival (OS) was demonstrated by Kaplan–Meier analysis, and the curves were compared by the log-rank test. Results: The median age of patients was 67.5 years (range: 46-83 years). Bone was the most common site of metastasis, except BoMI (n=8, 100%). At the time of diagnosis of BoMI, the most abnormal haematological findings were anaemia (87.5%) and thrombocytopenia (87.5%), followed by leucopenia (37.5%). The median time of BoMI was 16.8 months (range: 0-57.8). The median and mean OS after the diagnosis of BoMI were 38 days [95% confidence interval (CI); 0-175.2] and 143 days (95% CI; 27.7-259.9), respectively. According to the treatment status after BoMI, median OS were 215 days for patients who underwent oncologic treatment and 21 days in patients followed up with best supportive care (BSC) (p=0.014). Conclusion: BoMI in prostate cancer and other solid tumours remain a dismal situation. According to survival difference between the patients who received treatment and BSC after BoMI diagnosis, patients who are eligible for oncologic treatment should be encouraged for continuing the treatment.

Authors and Affiliations

Havva Yeşil Çınkır, Zehra Bozdağ

Keywords

Related Articles

The Influence of Class III Obesity on Subarachnoid Depth of Turkish Parturient: A Prospective Observational Study

Introduction: This observational study aimed to investigate the effects of morbid obesity on the subarachnoid depth and spinal anaesthesia technique. Methods: Sixty American Society of Anesthesiologists Classification I...

Investigation of Neutrophil-to-lymphocyte Ratio as a Biomarker to Evaluate Systemic Inflammation in Clinical Otosclerosis

Introduction: Otosclerosis with yet unexplained etiopathogenesis, especially for inflammatory mechanism, affects otic capsule of ear and causes progressive hearing loss. We aimed to investigate whether there is systemic...

Lumbar Ligamentum Flavum Cyst: Case Report

Ligamentum flavum cyst, a cystic lesion adjacent to the lumbar spine, is a rare cause of neurological symptoms and signs. It is usually seen in older ages. It is more common in the lower lumbar region than in the cervica...

Nanomaterials and Their Effects on Health

Nanotechnology, which includes many potential applications, is described as the technology of the future and the industrial revolution of the 21st century. The effect of nanotechnology is particularly evident in nanomate...

Effects of Anaemia Parameters on Metabolic Control in Children with Type-1 Diabetes Mellitus

Introduction: Anaemia parameters in children with type- 1 diabetes and their relationship with metabolic control has received little attention in the literature. We aimed to determine the incidence of anaemia and to inve...

Download PDF file
  • EP ID EP685085
  • DOI 10.4274/imj.galenos.2020.44341
  • Views 121
  • Downloads 0

How To Cite

Havva Yeşil Çınkır, Zehra Bozdağ (2020). Prostate Cancer and Bone Marrow Involvement. Istanbul Medical Journal, 21(3), -. https://europub.co.uk/articles/-A-685085